The Oxford-AstraZeneca Covid vaccine, sold as Covishield in India and Vaxzevria in Europe is a viral vector vaccine developed ...
In India, almost 90 per cent of people who received Covid-19 vaccine, received the AstraZeneca vaccine which in India is ...
AstraZeneca has confessed in court for the first time that its COVID-19 vaccine can cause fatal blood clotting adverse ...
A data scientist who has accurately predicted COVID waves since the beginning of the pandemic warns that a surge is on the ...
Thrombosis Thrombocytopenia Syndrome (TTS) -- a blood clot disorder -- is a rare side effect of AstraZeneca's Covid vaccine, ...
Thrombosis Thrombocytopenia Syndrome (TTS) — a blood clot disorder — is a rare side effect of AstraZeneca’s Covid vaccine, ...
UK court against biopharma company over claims that its Covid vaccine caused death and injury in several cases.
The petition filed by advocate Vishal Tiwari has cited documents reportedly submitted by the pharma giant AstraZeneca in a UK ...
AstraZeneca has maintained that while the vaccine may, in “very rare” cases, cause TTS, the casual mechanism for this effect ...
COVID-cautious Angelenos continue to take proactive steps to prevent infection, as they watch many others seem to care less ...
Fraunhofer SCAI coordinates the COMMUTE project, backed by a grant from the European Commission. Over the next four years, an interdisciplinary team ...
The AstraZeneca vaccine Vaxzevria was administered in India under the brand name Covishield and manufactured by the Serum ...